A direct effect of aldosterone on endothelin-1 gene expression in vivo

Stephen Wong1, Francine E Brennan, Morag J Young

  • 1Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria 3800, Australia.

Endocrinology
|January 16, 2007
PubMed

Insights

Endothelin-1 (ET-1) is a direct aldosterone target gene in the kidney and colon. Aldosterone rapidly increases ET-1 mRNA levels, suggesting its role in regulating ion homeostasis.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Physiology

Background:

  • Aldosterone is a key hormone regulating sodium reabsorption in epithelial tissues like the kidney and colon.
  • This process involves mineralocorticoid receptor (MR) activation, gene induction, and increased sodium channel activity.
  • Endothelin-1 (ET-1), a vasoconstrictor, influences kidney sodium and hydrogen ion transport.

Purpose of the Study:

  • To investigate Endothelin-1 (ET-1) as a direct aldosterone-regulated target gene in vivo.
  • To determine the role of the mineralocorticoid receptor (MR) in ET-1 gene regulation by aldosterone.

Main Methods:

  • Adrenalectomized rats were administered aldosterone and/or a MR antagonist (potassium canrenoate).
  • Quantitative real-time PCR was used to measure ET-1 mRNA levels in kidney and colon tissues.
  • Time course experiments assessed the rapid induction of ET-1 mRNA following aldosterone administration.

Main Results:

  • A single dose of aldosterone increased ET-1 mRNA levels 2-fold in the kidney and colon after 1 hour.
  • Aldosterone did not significantly affect mRNA levels of related isoforms ET-2 or ET-3.
  • Co-administration of aldosterone and a MR antagonist blocked ET-1 mRNA induction, confirming MR mediation.
  • ET-1 mRNA levels peaked at 2- and 2.5-fold increases in the kidney and colon, respectively, within 1 hour.

Conclusions:

  • Endothelin-1 (ET-1) is a direct aldosterone-induced gene target in the kidney and colon.
  • The mineralocorticoid receptor (MR) mediates aldosterone's effect on ET-1 gene expression.
  • ET-1 may play a significant role in aldosterone-mediated ion homeostasis.

Related Concept Videos

Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...